Directorate Change

Abingdon Health PLC
19 December 2024
 

 

Abingdon Health plc

("Abingdon Health", the "Group" or the "Company")

 

Directorate Change

Appointment of Chief Financial Officer

 

York, U.K. 19 December 2024: Abingdon Health plc (AIM: ABDX), a leading international lateral flow contract research (CRO) and contract development and manufacturing organisation (CDMO), announces the appointment of Tom Hayes as Chief Financial Officer ("CFO") and a Director of the Company. Tom will join Abingdon on 6 January 2025 on a part-time basis and will assume the full-time position by April 2025.

 

Tom has significant capital markets experience having spent the last ten years as Group Finance Director at Northern Bear plc, an AIM-listed Group of ten specialist building services companies assembled through an acquisition strategy. Tom has previously held roles at Sentio Insight LLP, a boutique advisory firm, providing a range of financial due diligence and transaction services, and Ernst & Young LLP, gaining corporate finance advisory experience in the private equity, corporate and public sectors. Tom qualified as a Chartered Accountant with Arthur Andersen & Co.


A person sitting at a desk Description automatically generated

 

Tom Hayes

Chief Financial Officer of Abingdon Health plc

 

Dr Chris Hand, Executive Chairman of Abingdon Health plc, commented: "I am delighted to welcome Tom to Abingdon Health plc as CFO and board director. This is a key time for Tom to join as we continue our growth, consolidate our recent acquisitions and expand our activities into the USA via our Madison, WI base. Tom has over 25 years' experience, particularly with AIM-listed companies, having worked as Group Finance Director at Northern Bear plc and prior to this in advisory roles. 2025 is going to be an exciting year for Abingdon with our upcoming growth plans and Tom with his expertise will be a great addition to the business."

 

Additional Disclosures Required under the AIM Rules for Companies

Thomas Edward Hayes (aged 48) has held the following directorship or partnerships in the past five years:

 

Current directorships/partnerships

Springs Roofing Limited

Alcor Handling Solutions Limited

H. Peel & Sons Limited

J Lister Electrical Limited

Isoler Limited

Jennings Roofing Limited

Previous directorships/partnerships (last five years)

Sab Invest LLP (Dissolved)

Lister Holdings (York) Limited (Dissolved)

Jennings Properties Limited (Dissolved)

H Peel & Sons (Holdings) Limited (Dissolved)

Maxaim Strategic and Financial Management Limited (Dissolved)

Arcas Building Solutions Limited


Northern Bear (Safety) Limited


Wensley Roofing Limited


MGM Limited


Northern Bear plc


SH Consultancy Oakwood Limited


Sentio Insight LLP


A1 Industrial Trucks Limited


System Roofing Services Limited


Northern Bear Construction Limited


Northern Bear Roofing Limited


Joom LLP


 

Tom Hayes and persons closely associated (as defined under MAR) with Mr Hayes do not hold any shares in the Company.

 

Save as disclosed above, there is no further information to be disclosed in respect of the above appointment pursuant to Rule 17 and Schedule 2 paragraph (g) of the AIM Rules for Companies.

 

Enquiries:

 

Abingdon Health plc

www.abingdonhealth.com/investors/

Chris Yates, Chief Executive Officer

Via Walbrook PR

Chris Hand, Executive Chairman




Zeus (Sole Broker and Nominated Adviser)

  Tel: +44 (0)20 3829 5000

Chris Fielding / Alexandra Campbell-Harris (Corporate Finance)


Fraser Marshall (Corporate Broking)

 



Walbrook PR (Media & Investor Relations)

Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

Phillip Marriage

+44 (0)7867 984 082

 

 

About Abingdon Health plc

Abingdon Health Group is a leading med-tech contract service provider offering its services to an international customer base.

 

The Company's CDMO division offers lateral flow product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health's CDMO division has the internal capabilities to take lateral flow projects, in areas such as infectious disease and clinical testing, including companion diagnostics, animal health and environmental testing, from initial concept through to routine and large-scale manufacturing; from "idea to commercial success".

 

Abingdon's regulatory services companies, Compliance Solutions (Life Sciences) and IVDeology, provide a broad range of regulatory services to the in vitro diagnostic and wider medical device industry, to support customers in bringing products to market across a range of territories including the USA, EU and the UK. Our consultancy services range from design, implementation and maintenance of quality management systems, preparation of technical files for regulatory approvals, part-time and interim management support, auditing both internal and external, management reviews and presentations, training and mentoring.

 

Abingdon Health's Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests to empowers consumers to manage their own health and wellbeing. The Abingdon Simply Test e-commerce site offers consumers a range of information to support them in making informed decisions on the tests available. In addition, the site provides Abingdon's contract services customers with a potential route to market for self-tests. The Abingdon Simply Test range is also sold through international distributors and through other channels in the UK and Ireland, such as pharmacy chains.

 

Founded in 2008, Abingdon Health is headquartered in York, England.

 

For more information visit: www.abingdonhealth.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100